发明名称 |
Pharmaceutical formulation containing gelling agent |
摘要 |
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient. |
申请公布号 |
US9040084(B2) |
申请公布日期 |
2015.05.26 |
申请号 |
US201313765368 |
申请日期 |
2013.02.12 |
申请人 |
Purdue Pharma L.P. |
发明人 |
Wright Curtis;Oshlack Benjamin;Breder Christopher |
分类号 |
A61K9/20;A61K47/36;A61K47/38;A61K31/167;A61K9/00;A61K31/439;A61K31/485;A61K47/10;A61K45/06;A61K31/192 |
主分类号 |
A61K9/20 |
代理机构 |
Lowenstein Sandler LLP |
代理人 |
Lowenstein Sandler LLP |
主权项 |
1. An immediate release oral dosage form comprising:
a mixture of (i) a therapeutically effective amount of oxycodone hydrochloride; and (ii) a gelling agent comprising starch, the gelling agent in an effective amount to impart a viscosity of at least about 10 cP to a solubilized mixture formed when the dosage form is subject to tampering by dissolution in from about 0.5 to about 10 ml of an aqueous liquid; wherein the weight ratio of the starch to the oxycodone hydrochloride is from less than 1:1 to about 1:3; and the dosage form provides an immediate release of the oxycodone hydrochloride when the dosage form is orally administered to a human patient. |
地址 |
Stamford CT US |